Report cover image

Vascular Imaging

Published May 01, 2026
Length 258 Pages
SKU # GJOB21161733

Description

REPORT HIGHLIGHTS

Global Vascular Imaging Market to Reach US$7.7 Billion by 2032

The global market for Vascular Imaging estimated at US$6.2 Billion in the year 2025, is expected to reach US$7.7 Billion by 2032, growing at a CAGR of 3.2% over the analysis period 2025-2032. CT Modality, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the MRI Modality segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 6.4% CAGR

The Vascular Imaging market in the U.S. is estimated at US$1.9 Billion in the year 2025. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2032 trailing a CAGR of 6.4% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Vascular Imaging Market - Key Trends & Drivers Summarized

What Is Driving the Adoption of Vascular Imaging Technologies?

Vascular imaging technologies have become indispensable in the diagnosis and management of vascular diseases, offering detailed visualizations of blood vessels and circulatory systems. The increasing prevalence of cardiovascular and peripheral vascular diseases has led to a surge in the demand for advanced imaging modalities such as ultrasound, magnetic resonance angiography (MRA), and computed tomography angiography (CTA). These technologies provide critical insights into vascular conditions, enabling early diagnosis, precise treatment planning, and effective monitoring of disease progression. As healthcare providers strive to improve patient outcomes and reduce the burden of vascular diseases, the adoption of vascular imaging technologies is expected to grow, driving market expansion.

How Are Technological Advancements Enhancing Vascular Imaging?

Technological advancements have significantly enhanced the capabilities of vascular imaging, making it more accurate, non-invasive, and accessible. The development of high-resolution imaging systems and contrast agents has improved the clarity and detail of vascular images, allowing for better detection of abnormalities and blockages. The integration of artificial intelligence (AI) and machine learning algorithms into imaging systems has further revolutionized the field, enabling automated image analysis and predictive diagnostics. Additionally, innovations in portable and point-of-care imaging devices have made vascular imaging more accessible, particularly in remote or underserved regions. These technological advancements are driving the widespread adoption of vascular imaging technologies, as they offer greater precision and convenience in the diagnosis and management of vascular diseases.

What Are the Emerging Trends in Vascular Imaging?

The vascular imaging market is witnessing several emerging trends that are shaping its growth and development. One notable trend is the increasing use of hybrid imaging techniques, such as PET/CT and PET/MRI, which combine the strengths of different imaging modalities to provide more comprehensive and accurate assessments of vascular conditions. Another trend is the growing emphasis on non-invasive imaging methods, driven by the need to reduce patient discomfort and the risk of complications associated with invasive procedures. The rise in demand for personalized medicine is also influencing the market, as imaging technologies are increasingly being used to tailor treatment plans based on individual patient profiles. Furthermore, the expanding use of AI-driven imaging analytics is enabling more precise and faster interpretation of vascular images, improving diagnostic accuracy and efficiency.

What Factors Are Driving the Growth of the Vascular Imaging Market?

The growth in the vascular imaging market is driven by several factors, including the rising prevalence of vascular diseases such as atherosclerosis, aneurysms, and deep vein thrombosis. The increasing demand for early and accurate diagnosis, fueled by the growing awareness of the importance of preventive healthcare, is also a significant driver. Additionally, the continuous advancements in imaging technologies, including the development of more sophisticated and non-invasive imaging systems, are expanding the range of diagnostic options available to healthcare providers. The shift towards value-based care, which emphasizes the importance of accurate diagnostics in improving patient outcomes and reducing healthcare costs, is further boosting the adoption of vascular imaging technologies. Moreover, the growing focus on research and development in the field of vascular imaging, supported by government initiatives and funding, is contributing to the market`s growth.

SCOPE OF STUDY:

The report analyzes the Vascular Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Modality (CT Modality, MRI Modality, Ultrasound Modality, Nuclear Medicine Modality); End-Use (Hospitals End-Use, Imaging Centers End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -
  • Abbott Laboratories
  • Carestream Health, Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Medical Systems USA
  • Siemens AG
  • Terumo Corporation
  • Toshiba Corporation
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Table of Contents

258 Pages
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
Vascular Imaging – Global Key Competitors Percentage Market Share in 2026 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Non-invasive Imaging Techniques
Technological Advancements in Vascular Ultrasound
Growth of MRI and CT Angiography in Vascular Diagnostics
Adoption of AI and Machine Learning in Vascular Imaging Analysis
Increasing Use of Portable and Handheld Imaging Devices
Expanding Applications of Vascular Imaging in Disease Screening
Innovations in Contrast Media and Imaging Agents
Integration of Imaging with Vascular Interventional Procedures
Growing Awareness and Early Diagnosis of Vascular Conditions
Cost-effectiveness and Accessibility of New Imaging Modalities
Rising Prevalence of Cardiovascular Diseases Globally
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Vascular Imaging Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
TABLE 2: World Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 3: World Historic Review for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 4: World 13-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
TABLE 5: World Recent Past, Current & Future Analysis for CT Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 6: World Historic Review for CT Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 7: World 13-Year Perspective for CT Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 8: World Recent Past, Current & Future Analysis for MRI Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 9: World Historic Review for MRI Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 10: World 13-Year Perspective for MRI Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 11: World Recent Past, Current & Future Analysis for Ultrasound Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 12: World Historic Review for Ultrasound Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 13: World 13-Year Perspective for Ultrasound Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 14: World Recent Past, Current & Future Analysis for Nuclear Medicine Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 15: World Historic Review for Nuclear Medicine Modality by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 16: World 13-Year Perspective for Nuclear Medicine Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 19: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 20: World Recent Past, Current & Future Analysis for Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 21: World Historic Review for Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 22: World 13-Year Perspective for Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 25: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
TABLE 26: USA Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 27: USA Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 28: USA 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 29: USA Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 30: USA Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 31: USA 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
CANADA
TABLE 32: Canada Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 33: Canada Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 34: Canada 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 35: Canada Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 36: Canada Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 37: Canada 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
JAPAN
Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
TABLE 38: Japan Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 39: Japan Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 40: Japan 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 41: Japan Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 42: Japan Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 43: Japan 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
CHINA
Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
TABLE 44: China Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 45: China Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 46: China 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 47: China Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 48: China Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 49: China 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
EUROPE
Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
TABLE 50: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 51: Europe Historic Review for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 52: Europe 13-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
TABLE 53: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 54: Europe Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 55: Europe 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 56: Europe Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 57: Europe Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 58: Europe 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
FRANCE
Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
TABLE 59: France Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 60: France Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 61: France 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 62: France Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 63: France Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 64: France 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
GERMANY
Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
TABLE 65: Germany Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 66: Germany Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 67: Germany 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 68: Germany Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 69: Germany Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 70: Germany 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
ITALY
TABLE 71: Italy Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 72: Italy Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 73: Italy 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 74: Italy Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 75: Italy Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 76: Italy 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
UNITED KINGDOM
Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
TABLE 77: UK Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 78: UK Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 79: UK 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 80: UK Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 81: UK Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 82: UK 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
SPAIN
TABLE 83: Spain Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 84: Spain Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 85: Spain 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 86: Spain Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 87: Spain Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 88: Spain 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
RUSSIA
TABLE 89: Russia Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 90: Russia Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 91: Russia 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 92: Russia Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 93: Russia Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 94: Russia 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
REST OF EUROPE
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 96: Rest of Europe Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 97: Rest of Europe 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 99: Rest of Europe Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 100: Rest of Europe 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
AUSTRALIA
Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
TABLE 101: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 102: Latin America Historic Review for Vascular Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 103: Latin America 13-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
TABLE 104: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 105: Latin America Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 106: Latin America 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 107: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 108: Latin America Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 109: Latin America 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
ARGENTINA
TABLE 110: Argentina Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 111: Argentina Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 112: Argentina 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 113: Argentina Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 114: Argentina Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 115: Argentina 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
BRAZIL
TABLE 116: Brazil Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 117: Brazil Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 118: Brazil 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 119: Brazil Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 120: Brazil Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 121: Brazil 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
MEXICO
TABLE 122: Mexico Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 123: Mexico Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 124: Mexico 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 125: Mexico Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 126: Mexico Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 127: Mexico 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
REST OF LATIN AMERICA
TABLE 128: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 129: Rest of Latin America Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 130: Rest of Latin America 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 131: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 132: Rest of Latin America Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 133: Rest of Latin America 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
MIDDLE EAST
Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
TABLE 134: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 135: Middle East Historic Review for Vascular Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 136: Middle East 13-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
TABLE 137: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 138: Middle East Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 139: Middle East 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 140: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 141: Middle East Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 142: Middle East 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
IRAN
TABLE 143: Iran Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 144: Iran Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 145: Iran 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 146: Iran Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 147: Iran Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 148: Iran 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
ISRAEL
TABLE 149: Israel Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 150: Israel Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 151: Israel 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 152: Israel Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 153: Israel Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 154: Israel 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
SAUDI ARABIA
TABLE 155: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 156: Saudi Arabia Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 157: Saudi Arabia 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 158: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 159: Saudi Arabia Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 160: Saudi Arabia 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
UNITED ARAB EMIRATES
TABLE 161: UAE Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 162: UAE Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 163: UAE 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 164: UAE Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 165: UAE Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 166: UAE 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
REST OF MIDDLE EAST
TABLE 167: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 168: Rest of Middle East Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 169: Rest of Middle East 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 170: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 171: Rest of Middle East Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 172: Rest of Middle East 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
AFRICA
Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
TABLE 173: Africa Recent Past, Current & Future Analysis for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 174: Africa Historic Review for Vascular Imaging by Modality - CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 175: Africa 13-Year Perspective for Vascular Imaging by Modality - Percentage Breakdown of Value Sales for CT Modality, MRI Modality, Ultrasound Modality and Nuclear Medicine Modality for the Years 2020, 2026 & 2032
TABLE 176: Africa Recent Past, Current & Future Analysis for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 177: Africa Historic Review for Vascular Imaging by End-Use - Hospitals End-Use, Imaging Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 178: Africa 13-Year Perspective for Vascular Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Imaging Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
IV. COMPETITION
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.